Bonora, B. M., Raschi, E., Avogaro, A., & Fadini, G. P. (2021). SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system. Cardiovasc Diabetol.
Citação norma ChicagoBonora, Benedetta Maria, Emanuel Raschi, Angelo Avogaro, and Gian Paolo Fadini. "SGLT-2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System." Cardiovasc Diabetol 2021.
Citação norma MLABonora, Benedetta Maria, Emanuel Raschi, Angelo Avogaro, and Gian Paolo Fadini. "SGLT-2 inhibitors and Atrial Fibrillation in the Food and Drug Administration Adverse Event Reporting System." Cardiovasc Diabetol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.